These findings suggest that glutamatergic excitotoxic damage could characterize the progressive MS phenotypes as demonstrated by in vitro studies showing hyperexcitability and enhanced neuronal damage induced by CSF collected from progressive MS patients, mediated by TNF (115). The gene discussed is TNF; the disease is myeloid sarcoma.